Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Stereotaxis
AddedFeb 19, 2024
UpdatedJun 18, 2026
Stereotaxis

Stereotaxis

Public

Stereotaxis Inc., a US-based firm, innovates in medical robotics, enhancing electrophysiology outcomes with products like NIOBE® ES RMN System.

HQ
St. Louis, MO, US
Founded
1990
Overview
Compare
Fundraising
Employees
Website

Stereotaxis Inc., founded in St. Louis, MO, is a publicly traded American medical robotics company focused on enhancing clinical outcomes in electrophysiology. The company's core mission is to advance interventional medicine through innovative robotic technologies. Their flagship product, the NIOBE® ES Remote Magnetic Navigation (RMN) System, allows for precise and minimally invasive procedures, targeting small areas within the body for ablation, biopsy, and other interventions. Stereotaxis primarily serves healthcare professionals and patients seeking advanced treatment options.

Notable figures associated with Stereotaxis include its leadership team and key investors who have supported its growth and technological advancements. The company has achieved significant milestones, including widespread adoption of its RMN system in leading medical institutions globally. Stereotaxis' impact is evident in improved patient outcomes and the advancement of minimally invasive surgical techniques, solidifying its position as a pioneer in the field of medical robotics.

Stereotaxis - Quick Facts

When was Stereotaxis founded?

Stereotaxis was founded in 1990.

Where is Stereotaxis' headquarters located?

Stereotaxis' headquarters is located in St. Louis, MO, US.

When was Stereotaxis' last funding round?

Stereotaxis' most recent funding round was for $25M (USD) in August 2019.

How much has Stereotaxis raised to-date?

As of Aug 8, 2019, Stereotaxis has raised a total of $105M (USD).

How many employees does Stereotaxis have?

Stereotaxis has 130 employees as of Feb 6, 2024.

Stereotaxis - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Robotics
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Robotics
Tags
  • Healthtech
  • Medical
Unique IDs
  • ein: 943120386
  • secCik: 0001289340
  • ticker: STXS
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334517Irradiation Apparatus Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3845Electromedical And Electrotherapeutic Apparatus
ISIC
  • 2660Manufacture of irradiation, electromedical and electrotherapeutic equipment
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8040Offices And Clinics Of Other Health Practitioners
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified